Data / Form D filings / Octave Bioscience Inc
Octave Bioscience Inc: Form D filings
Octave Bioscience Inc, a health care company in Menlo Park, CA, filed 5 Form D notices with the SEC between 2017 and 2025. The latest, on March 24, 2025, reports $31.8 million sold of a $53.7 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1440 O'BRIEN DRIVE, SUITE B, Menlo Park, CA, 94025
- Phone
- (917) 838-2865
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1702278
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | New notice | $53,674,121 | $31,840,355 | $21,833,766 | 20 | Mar 7, 2025 | sec.gov |
| Nov 24, 2023 | New notice | $6,999,999 | $6,999,999 | 2 | Sep 26, 2023 | sec.gov | |
| Nov 24, 2023 | New notice | $37,505,524 | $32,500,070 | $5,005,454 | 20 | Jan 4, 2023 | sec.gov |
| Jan 7, 2021 | New notice | $32,000,000 | $32,000,000 | 14 | Oct 29, 2020 | sec.gov | |
| Sep 13, 2017 | New notice | $2,500,000 | $2,500,000 | 7 | Nov 26, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| A. Grant Heidrich III | Director | |
| George Scangos | Director | |
| William Hagstrom | Director | |
| Marcel Konrad | Executive Officer | |
| Thomas Hawes | Director | |
| Brook Byers | Director | |
| Doug Biehn | Executive Officer, Director | |
| Lucy Coassin | Director | |
| Michael Pellini | Director |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Mar 24, 2025 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Octave Bioscience Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.